Viridian Therapeutics
VRDN
#4803
Rank
S$2.04 B
Marketcap
$25.82
Share price
1.60%
Change (1 day)
-13.24%
Change (1 year)

Earnings for Viridian Therapeutics (VRDN)

Earnings in 2024 (TTM): -S$0.34 Billion

According to Viridian Therapeutics's latest financial reports the company's current earnings are S$0.3 Million. In 2023 the company made an earning of -S$0.33 Billion a decrease over its 2022 earnings that were of -S$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viridian Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.34 Billion5.01%
2023 -S$0.33 Billion82.31%
2022 -S$0.18 Billion62.82%
2021 -S$0.11 Billion-27.89%
2020 -S$0.15 Billion168.55%
2019 -S$55.68 Million28.93%
2018 -S$43.19 Million21.82%
2017 -S$35.45 Million107.72%
2016 -S$17.07 Million12.44%
2015 -S$15.18 Million62.91%
2014 -S$9.32 Million3399.7%
2013 -S$0.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.19 Billion-46.94%๐Ÿ‡บ๐Ÿ‡ธ USA